Building an Integrated Biopharma Company: Crucell (B)
Below are the available bulk discount rates for each individual item when you purchase a certain amount
Register as a Premium Educator at hbsp.harvard.edu, plan a course, and save your students up to 50% with your academic discount.
Publication Date:
February 25, 2015
Industry:
Pharmaceuticals
Industry:
Professional Services
Source:
Harvard Business School
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8 billion.
If you’d like to share this PDF, you can purchase copyright permissions by increasing the quantity.
Copyright © 2021 Harvard Business School Publishing. All rights reserved. Harvard Business Publishing is an affiliate of Harvard Business School.
Building an Integrated Biopharma Company: Crucell (B)
Research & References of Building an Integrated Biopharma Company: Crucell (B)|A&C Accounting And Tax Services
Source